{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:45:11Z","timestamp":1793126711416,"version":"4.5.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"1160","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Innovation Project of Guangxi Graduate Education","award":["YCBZ2023092"],"award-info":[{"award-number":["YCBZ2023092"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To investigate the clinical character of differentiated thyroid cancer (DTC) coexisting with Hashimoto\u2019s thyroiditis (HT) and provide state-of-art evidence for personalized radioactive iodine-131 therapy (RAIT) for patients coexisting with HT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>From January 2000 to January 2023, PubMed, Embase, and Web of Science databases were searched for relevant original articles that published in English on the RAIT efficacy for DTC with HT. RevMan 5.4 and Stata 17.0 were used for data analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Eleven studies involving 16\u00a0605 DTC patients (3321 with HT) were included. HT was more frequent in female (OR: 2.90, 95% confidence interval [CI]: 1.77-4.76, P\u2009&amp;lt;\u2009.00001). The size of tumour (MD: \u22120.20, 95% CI: \u22120.30 to \u22120.11), extrathyroidal extension rate (OR: 0.77, 95% CI: 0.67-0.90), and metastasis rate (OR: 0.18, 95% CI: 0.08-0.41) were less in HT, but tumour, node, metastasis (TNM) stage had no significant difference among HT and non-HT group. Disease-free survival (DFS) rate (OR: 1.96, 95% CI: 1.57-2.44, P\u2009&amp;lt;\u2009.00001), 5-year DFS (OR: 1.73, 95% CI: 1.04-2.89, P\u2009=\u2009.04), and 10-year DFS (OR: 1.56, 95% CI: 1.17-2.09, P\u2009=\u2009.003) were higher in HT group. The recurrent (OR: 0.62, 95% CI: 0.45-0.83, P\u2009=\u2009.002), RAIT dosage (MD = \u221238.71, 95% CI: \u221260.86 to \u221216.56, P\u2009=\u2009.0006), and treatment (MD: \u22120.13, 95% CI: \u22120.22 to \u22120.03, P\u2009=\u2009.008) were less in HT group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>DTC coexisting with HT was associated with less invasion. DFS of HT group was higher than non-HT group after RAIT. Low-dose treatment did not impair the efficacy of RAIT in DTC with HT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Advances in knowledge<\/jats:title>\n                  <jats:p>Hashimoto\u2019s thyroiditis is a risk for DTC, but it minimalizes the progression of cancer and enhance the efficacy of RAIT, which should be considered in personalizing RAIT.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjr\/tqae118","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T11:52:03Z","timestamp":1718365923000},"page":"1423-1430","source":"Crossref","is-referenced-by-count":4,"title":["Radioactive iodine therapy for thyroid cancer coexisting with Hashimoto\u2019s thyroiditis: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"97","author":[{"given":"Xiang-Yi","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, The First Affiliated Hospital of Guangxi Medical University , Nanning 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Guangxi Medical University , Nanning 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Sixth Medical Center of PLA General Hospital , Beijing 100048, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3466-2902","authenticated-orcid":false,"given":"Zhi-Xiao","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The First Affiliated Hospital of Guangxi Medical University , Nanning 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"issue":"4-5","key":"2024071814515014700_tqae118-B1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","article-title":"Hashimoto thyroiditis: clinical and diagnostic criteria","volume":"13","author":"Caturegli","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"6","key":"2024071814515014700_tqae118-B2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bjorl.2017.08.012","article-title":"Hashimoto\u2019s thyroiditis\u2014an independent risk factor for papillary carcinoma","volume":"84","author":"Uhliarova","year":"2018","journal-title":"Braz J Otorhinolaryngol"},{"issue":"2","key":"2024071814515014700_tqae118-B3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.14639\/0392-100X-N1081","article-title":"Hashimoto\u2019s thyroiditis in papillary thyroid carcinoma: a 22-year study","volume":"41","author":"Hanege","year":"2021","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"4","key":"2024071814515014700_tqae118-B4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/thy.2019.0347","article-title":"Incidentally discovered papillary thyroid microcarcinomas are more frequently found in patients with chronic lymphocytic thyroiditis than with multinodular goiter or Graves\u2019 disease","volume":"30","author":"Paparodis","year":"2020","journal-title":"Thyroid"},{"issue":"6","key":"2024071814515014700_tqae118-B5","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00432-014-1629-z","article-title":"The study of the coexistence of Hashimoto\u2019s thyroiditis with papillary thyroid carcinoma","volume":"140","author":"Zhang","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"2024071814515014700_tqae118-B6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2024071814515014700_tqae118-B7","doi-asserted-by":"crossref","first-page":"e220293","DOI":"10.1530\/ERC-22-0293","article-title":"The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading","volume":"30","author":"Christofer Juhlin","year":"2023","journal-title":"Endocr Relat Cancer"},{"issue":"31","key":"2024071814515014700_tqae118-B8","doi-asserted-by":"crossref","first-page":"eabf3657","DOI":"10.1126\/sciadv.abf3657","article-title":"Characterizing dedifferentiation of thyroid cancer by integrated analysis","volume":"7","author":"Luo","year":"2021","journal-title":"Sci Adv"},{"issue":"8","key":"2024071814515014700_tqae118-B9","first-page":"e28054","article-title":"Hashimoto\u2019s thyroiditis effects on papillary thyroid carcinoma outcomes: a systematic review","volume":"14","author":"Osborne","year":"2022","journal-title":"Cureus"},{"issue":"2007","key":"2024071814515014700_tqae118-B10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"6","key":"2024071814515014700_tqae118-B11","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"2024071814515014700_tqae118-B12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"2024071814515014700_tqae118-B13","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1177\/09622802231172043","article-title":"Detecting the skewness of data from the five-number summary and its application in meta-analysis","volume":"32","author":"Shi","year":"2023","journal-title":"Stat Methods Med Res"},{"issue":"10","key":"2024071814515014700_tqae118-B14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s12149-021-01644-1","article-title":"The role of Hashimoto thyroiditis in predicting radioiodine ablation efficacy and prognosis of low to intermediate risk differentiated thyroid cancer","volume":"35","author":"Albano","year":"2021","journal-title":"Ann Nucl Med"},{"issue":"6","key":"2024071814515014700_tqae118-B15","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1210\/jc.2013-1309","article-title":"Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimoto\u2019s thyroiditis","volume":"98","author":"Dvorkin","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024071814515014700_tqae118-B16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12022-011-9164-9","article-title":"Well-differentiated thyroid carcinoma with concomitant Hashimoto\u2019s thyroiditis present with less aggressive clinical stage and low recurrence","volume":"22","author":"Huang","year":"2011","journal-title":"Endocr Pathol"},{"issue":"4","key":"2024071814515014700_tqae118-B17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2265.2009.03537.x","article-title":"Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma","volume":"71","author":"Kim","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2024071814515014700_tqae118-B18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3349\/ymj.2014.55.4.879","article-title":"Pathologic spectrum of lymphocytic infiltration and recurrence of papillary thyroid carcinoma","volume":"55","author":"Kim","year":"2014","journal-title":"Yonsei Med J"},{"issue":"7","key":"2024071814515014700_tqae118-B19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/00365513.2015.1057895","article-title":"IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent\/recurrent disease in papillary thyroid carcinoma with\/without Hashimoto's thyroiditis","volume":"75","author":"Stanciu","year":"2015","journal-title":"Scand J Clin Lab Invest"},{"issue":"3","key":"2024071814515014700_tqae118-B20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/cen.13367","article-title":"Prognostic value of preoperative anti-thyroglobulin antibody in differentiated thyroid cancer","volume":"87","author":"Jo","year":"2017","journal-title":"Clin Endocrinol"},{"issue":"3","key":"2024071814515014700_tqae118-B21","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s12020-016-1185-1","article-title":"Chronic lymphocytic thyroiditis does not influence the risk of recurrence in patients with papillary thyroid carcinoma and excellent response to initial therapy","volume":"55","author":"Carvalho","year":"2017","journal-title":"Endocrine"},{"issue":"6","key":"2024071814515014700_tqae118-B22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1308\/rcsann.2021.0224","article-title":"Hashimoto\u2019s thyroiditis on outcomes in papillary thyroid cancer revisited: experience from South East Asia","volume":"104","author":"Lau","year":"2022","journal-title":"Ann R Coll Surg Engl"},{"issue":"9","key":"2024071814515014700_tqae118-B23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/ERC-17-0085","article-title":"Hashimoto\u2019s thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer","volume":"24","author":"Marotta","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"2024071814515014700_tqae118-B24","doi-asserted-by":"crossref","first-page":"e2118526","DOI":"10.1001\/jamanetworkopen.2021.18526","article-title":"Prevalence of Hashimoto thyroiditis in adults with papillary thyroid cancer and its association with cancer recurrence and outcomes","volume":"4","author":"Xu","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2024071814515014700_tqae118-B25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","article-title":"The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020","volume":"10","author":"Pizzato","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2024071814515014700_tqae118-B26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/thy.2018.0509","article-title":"Poorly differentiated carcinoma of the thyroid gland: current status and future prospects","volume":"29","author":"Ibrahimpasic","year":"2019","journal-title":"Thyroid"},{"issue":"1","key":"2024071814515014700_tqae118-B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"12","key":"2024071814515014700_tqae118-B28","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.tem.2014.09.001","article-title":"Hashimoto\u2019s thyroiditis and papillary thyroid cancer: are they immunologically linked?","volume":"25","author":"Ehlers","year":"2014","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"2024071814515014700_tqae118-B29","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1245\/s10434-019-07256-4","article-title":"Thyroid antibody status is associated with central lymph node metastases in papillary thyroid carcinoma patients with Hashimoto\u2019s thyroiditis","volume":"26","author":"Wen","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2024071814515014700_tqae118-B30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S2213-8587(18)30306-1","article-title":"Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial","volume":"7","author":"Dehbi","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024071814515014700_tqae118-B31","first-page":"E730","article-title":"Effect of Hashimoto thyroiditis on low-dose radioactive-iodine remnant ablation","volume":"38(Suppl 1)","author":"Kwon","year":"2016","journal-title":"Head Neck"},{"issue":"6","key":"2024071814515014700_tqae118-B32","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.3390\/curroncol29060342","article-title":"Prognostic and predictive relevance of tumor-infiltrating lymphocytes in squamous cell head-neck cancer patients treated with radical radiotherapy\/chemo-radiotherapy","volume":"29","author":"Koukourakis","year":"2022","journal-title":"Curr Oncol"},{"issue":"2","key":"2024071814515014700_tqae118-B33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/0284186X.2021.1989629","article-title":"Tumor-infiltrating lymphocytes predict improved overall survival after post-mastectomy radiotherapy: a study of the randomized DBCG82bc cohort","volume":"61","author":"Tramm","year":"2022","journal-title":"Acta Oncol"},{"issue":"3","key":"2024071814515014700_tqae118-B34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.asjsur.2015.08.002","article-title":"Prognosis of papillary thyroid cancers with positive serum thyroglobulin antibody after total thyroidectomy","volume":"40","author":"Kuo","year":"2017","journal-title":"Asian J Surg"},{"key":"2024071814515014700_tqae118-B35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3389\/fendo.2020.00452","article-title":"Clinical analysis of preoperative anti-thyroglobulin antibody in papillary thyroid cancer between 2011 and 2015 in Beijing, China: a retrospective study","volume":"(7)","author":"Jia","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2024071814515014700_tqae118-B36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/jc.2014-2725","article-title":"Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer","volume":"100","author":"Lupoli","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"2024071814515014700_tqae118-B37","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1001\/jama.2020.22196","article-title":"Autoimmune thyroid disease in women","volume":"325","author":"Mammen","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"2024071814515014700_tqae118-B38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00281-018-0723-8","article-title":"Sex differences in autoimmune disorders of the central nervous system","volume":"41","author":"Gold","year":"2019","journal-title":"Semin Immunopathol"},{"key":"2024071814515014700_tqae118-B39","doi-asserted-by":"crossref","first-page":"945762","DOI":"10.3389\/fimmu.2022.945762","article-title":"Sex bias in lymphocytes: implications for autoimmune diseases","volume":"11)","author":"Dodd","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"2024071814515014700_tqae118-B40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mce.2017.03.006","article-title":"Frequencies of PD-1- positive T CD3+CD4+, T CD3+CD8+ and B CD19+ lymphocytes in female patients with Graves\u2019 disease and healthy controls- preliminary study","volume":"448","author":"Pyzik","year":"2017","journal-title":"Mol Cell Endocrinol"},{"issue":"15","key":"2024071814515014700_tqae118-B41","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1158\/1078-0432.CCR-11-0207","article-title":"Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regression","volume":"17","author":"Li","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2024071814515014700_tqae118-B42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10555-021-09968-0","article-title":"Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer","volume":"40","author":"Nelson","year":"2021","journal-title":"Cancer Metastasis Rev"},{"issue":"11","key":"2024071814515014700_tqae118-B43","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","article-title":"Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes","volume":"72","author":"Calcinotto","year":"2012","journal-title":"Cancer Res"},{"key":"2024071814515014700_tqae118-B44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-3-030-34461-0_18","article-title":"Hypoxia compromises anti-cancer immune responses","volume":"1232","author":"Multhoff","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"2024071814515014700_tqae118-B45","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41467-022-28120-2","article-title":"Lymphocyte infiltration and thyrocyte destruction are driven by stromal and immune cell components in Hashimoto's thyroiditis","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"issue":"11","key":"2024071814515014700_tqae118-B46","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1007\/s00268-018-4662-2","article-title":"The updated AJCC\/TNM staging system for papillary thyroid cancer (8th Edition): from the perspective of genomic analysis","volume":"42","author":"Kim","year":"2018","journal-title":"World J Surg"},{"issue":"4","key":"2024071814515014700_tqae118-B47","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1677\/erc.1.01320","article-title":"Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition","volume":"13","author":"Chow","year":"2006","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2024071814515014700_tqae118-B48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2018.10.001","article-title":"The current histologic classification of thyroid cancer","volume":"48","author":"Asa","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"2024071814515014700_tqae118-B49","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3803\/EnM.2022.1553","article-title":"Update from the 2022 World Health Organization classification of thyroid tumors: a standardized diagnostic approach","volume":"37","author":"Jung","year":"2022","journal-title":"Endocrinol Metab (Seoul)"}],"container-title":["British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/advance-article-pdf\/doi\/10.1093\/bjr\/tqae118\/58354266\/tqae118.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/97\/1160\/1423\/58588828\/tqae118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/97\/1160\/1423\/58588828\/tqae118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T15:40:49Z","timestamp":1721317249000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/97\/1160\/1423\/7693067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":49,"journal-issue":{"issue":"1160","published-online":{"date-parts":[[2024,6,13]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bjr\/tqae118","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"value":"0007-1285","type":"print"},{"value":"1748-880X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,6,13]]}}}